News

Jun 9, 2009

miRagen Therapeutics, Inc. extends Series A to $12M

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA...

May 13, 2009

CardiAQ Valve Technologies receives seed funding from Broadview Ventures

CardiAQ Valve Technologies (CVT) received $750,000 in seed or ‘translational’ funding from Broadview Ventures Inc.—a...